Stargardt Clinical Trials in Beijing, Beijing Municipality
2 recruitingBeijing, Beijing Municipality, China
Showing 1–2 of 2 trials
Recruiting
Early Phase 1
The Safety and Efficacy of ZVS106e in the Treatment of IRDs Caused by Biallelic Mutations in ABCA4
Stargardt
Zhongshan Ophthalmic Center, Sun Yat-sen University9 enrolled2 locationsNCT07241169
Recruiting
Phase 1
A Study of DC6001 Tablet in Healthy Chinese Adult Subjects
Stargardt Disease
Heronova Pharmaceuticals76 enrolled1 locationNCT07417566